Anders Fernström

Dr. Anders Fernström


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JPJoosep Paats
Joosep Paats
AAAnnika Adoberg
Annika Adoberg
JAJürgen Arund
Jürgen Arund
ADAnnemieke Dhondt
Annemieke Dhondt
AFAnders Fernström
Anders Fernström
AOAlberto Ortiz
Alberto Ortiz
Tryptophan is an essential dietary amino acid that originates uremic toxins that contribute to end-stage kidney disease (ESKD) patient outcomes. We evaluated serum levels and removal during haemodialysis and haemodiafiltration of tryptophan and tryptophan-derived uremic toxins, indoxyl sulfate (IS) and indole acetic acid (IAA), in ESKD patients in different dialysis treatment settings. This prospective multicentre study in four European dialysis centres enrolled 78 patients with ESKD. Blood and spent dialysate samples obtained during dialysis were analysed with high-performance liquid chromatography to assess uremic solutes, their reduction ratio (RR) and total removed solute (TRS). Mean free serum tryptophan and IS concentrations increased, and concentration of IAA decreased over pre-dialysis levels (67%, 49%, −0.8%, respectively) during the first hour of dialysis. While mean serum total urea, IS and IAA concentrations decreased during dialysis (−72%, −39%, −43%, respectively), serum tryptophan levels increased, resulting in negative RR (−8%) towards the end of the dialysis session (p < 0.001), despite remarkable Trp losses in dialysate. RR and TRS values based on serum (total, free) and dialysate solute concentrations were lower for conventional low-flux dialysis (p < 0.001). High-efficiency haemodiafiltration resulted in 80% higher Trp losses than conventional low-flux dialysis, despite similar neutral Trp RR values. In conclusion, serum Trp concentrations and RR behave differently from uremic solutes IS, IAA and urea and Trp RR did not reflect dialysis Trp losses. Conventional low-flux dialysis may not adequately clear Trp-related uremic toxins while high efficiency haemodiafiltration increased Trp losses.

27 February 2015 in Toxins
Verified
Journal Article
Open access
PDF file
JHJana Holmar
Jana Holmar
FUFredrik Uhlin
Fredrik Uhlin
AFAnders Fernström
Anders Fernström
MLMerike Luman
Merike Luman
JJJoachim Jankowski
Joachim Jankowski
IFIvo Fridolin
Ivo Fridolin
Survival among hemodialysis patients is disturbingly low, partly because vascular calcification (VC) and cardiovascular disease are highly prevalent. Elevated serum phosphorus (P) and calcium (Ca) levels play an essential role in the formation of VC events. The purpose of the current study was to reveal optical monitoring possibilities of serum P and Ca values during dialysis. Twenty-eight patients from Tallinn (Estonia) and Linköping (Sweden) were included in the study. The serum levels of Ca and P on the basis of optical information, i.e., absorbance and fluorescence of the spent dialysate (optical method) were assessed. Obtained levels were compared in means and SD. The mean serum level of Ca was 2.54 ± 0.21 and 2.53 ± 0.19 mmol/L; P levels varied between 1.08 ± 0.51 and 1.08 ± 0.48 mmol/L, measured in the laboratory and estimated by the optical method respectively. The levels achieved were not significantly different (p = 0.5). The Bland-Altman 95% limits of agreement between the two methods varied from −0.19 to 0.19 for Ca and from −0.37 to 0.37 in the case of P. In conclusion, optical monitoring of the spent dialysate for assessing the serum levels of Ca and P during dialysis seems to be feasible and could offer valuable and continuous information to medical staff.

9 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
MHMathias Haarhaus
Mathias Haarhaus
AFAnders Fernström
Anders Fernström
AQAbdul Rashid Qureshi
Abdul Rashid Qureshi
PMPer Magnusson
Per Magnusson
Circulating alkaline phosphatase (ALP) is an independent cardiovascular risk marker. Serum bone ALP (BALP) isoforms indicate bone turnover and comprise approximately 50% of total circulating ALP. In chronic kidney disease (CKD), mortality is highest in patients with increased ALP and BALP and low bone turnover. However, not all low bone turnover states are associated with increased mortality. Chronic inflammation and oxidative stress, features of protein energy wasting syndrome, induce cardiovascular BALP activity and fibro-calcification, while bone turnover is suppressed. Circulating BALP isoform B1x is associated with low ALP and low bone turnover and has been exclusively detected in CKD. We investigated the association of serum B1x with survival, abdominal aortic calcification (AAC) score, and aortic pulse wave velocity (PWV) in CKD. Serum ALP, BALP isoforms, parathyroid hormone (PTH), PWV, and AAC were measured repeatedly over 2 years in 68 prevalent dialysis patients. Mortality was assessed after 5 years. B1x was detected in 53 patients. A competing risk analysis revealed an association of B1x with improved 5-year survival; whereas, baseline PWV, but not AAC score, predicted mortality. However, PWV improved in 26 patients (53%), and B1x was associated with variation of PWV over time (p = 0.03). Patients with B1x had lower PTH and total ALP, suggesting an association with lower bone turnover. In conclusion, B1x is associated with time-varying PWV, lower circulating ALP, and improved survival in CKD, and thus may be an indicator of a reduced cardiovascular risk profile among patients with low bone turnover.

29 December 2021 in Research Square
Verified
Preprint
Open access
PDF file
AIAinhoa Indurain
Ainhoa Indurain
JLJennifer Linge
Jennifer Linge
MPMikael Petersson Petersson
Mikael Petersson Petersson
TRThobias Romu
Thobias Romu
FUFredrik Uhlin
Fredrik Uhlin
OLOlof Dahlqvist Leinhard
Olof Dahlqvist Leinhard
BackgroundSarcopenia is a prevalent condition in patients on maintenance hemodialysis and associates with mortality. Research using magnetic resonance imaging (MRI) has demonstrated the importance of a proper body size-adjustment in the assessment of muscle mass, and that a muscle composition assessment including measurements of both muscle volume and fat infiltration improves the prediction of comorbidity and survival related to sarcopenia. Such combined muscle composition assessment has not previously been performed in hemodialysis patients.MethodsEleven hemodialysis patients were scanned using whole-body fat and water separated MRI and followed regarding survival and comorbidity for five years. Muscle composition was assessed using AMRA® Researcher. Using data from 9615 UK Biobank participants, sex and BMI-matched muscle volume z-scores and sex-adjusted muscle fat infiltration values were calculated for each patient. These measurements were then used for the calculation of a combined muscle score. Resulting three muscle measurements were associated with survival and comorbidity index.ResultsSix patients exhibited low muscle volume (muscle volume z-score 75th percentile (population wide)). During a 68-months follow-up, five patients died, four were transplanted and two remained on hemodialysis treatment. The combined muscle score was significantly associated with comorbidity index (p<0.05) and was highly predictive of survival (AUROC 0.97).ConclusionsThe combined assessment including both body size-adjusted muscle volume and muscle fat infiltration can be used to analyze muscle composition in hemodialysis patients. MRI based muscle composition assessment reflected comorbidity and predicted survival in hemodialysis patients.